Engineering extremely strong immune systems.
Our company scientists have successfully combined multiple immune systems, to form an extremely strong immune system. The resultant immuno-therapeutic product (AbstimX™) has been validated in mouse studies at our laboratory at the University of Toronto, to prevent both breast cancer and inflammatory bowel disease. We are confident that AbstimX™ will also be effective for the prevention of other cancers and other inflammatory/autoimmune diseases.
Network Immunology Inc. is a privately held biotech company that develops patented immuno-therapeutics based on immune network theory.
CSO Geoffrey W. Hoffman Explains Immune Network Theory. ..
CEO George Hoffman discusses Network Immunology's latest research breakthrough in organ transplantation. ..
Toronto, ON: Network Immunology has received breakthrough data for its platform Co-selection Technology™ that has potential applications to transplantation, autoimmunity and other degenerati..